Brainstorm Cell Therapeutics amends bylaws to reduce quorum to 1/3; sets 2025 annual meeting for June 25

BRAINSTORM CELL THERAPEUTICS INC.

Board approved reducing stockholder quorum from majority to one-third of outstanding shares.
2025 Annual Meeting to be held virtually on June 25, 2025 at 10:00 a.m. ET.
Record date for voting is May 7, 2025; shareholder proposals due by same date.
Director nominations under universal proxy rules must be received by May 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BRAINSTORM CELL THERAPEUTICS INC.: Reduced quorum requirement for stockholder meetings from majority to one-third (effective 2025-04-20).

Change: bylaw amendment
Effective: 2025-04-20

Exact text from the filing

On April 20, 2025, the Board of Directors (the “Board”) of Brainstorm Cell Therapeutics Inc. (the “Company”) approved an amendment (“ Bylaws Amendment”) to the Company’s bylaws, as amended, to reduce the quorum requirement for all meetings of stockholders from a majority in interest of all of the Company’s stock that is issued and outstanding and entitled to vote to one-third (1/3) in interest of all of the Company’s stock that is issued and outstanding and entitled to vote at such meeting, as permitted under the Delaware General Corporation Law.

View on SEC.gov

40 governance changes filed in the last 30 days. Browse all governance changes →

BRAINSTORM CELL THERAPEUTICS INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-036851

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.